[Studies on expansion ex vivo of murine bone marrow cells and its hematopoietic reconstitution capacity]

Zhonghua Xue Ye Xue Za Zhi. 1997 Aug;18(8):413-6.
[Article in Chinese]

Abstract

Objective: To investigate the effects of stem cell factor (SCF) in combination with interleukin-1 (IL-1) or/and interleukin-3 (IL-3) on ex vivo expansion of 5FU treated bone marrow cells and hematopoietic recovery in lethally irradiated mice transplanted with the expanded cells.

Methods: 5FU treated bone marrow cells (d3-5FU-BMC) were cultured in a cytokines-containing medium, and the net increments of CFU-GM and high proliferative potential colony forming cell (HPP-CFC) were evaluated.

Results: CFU-GM increased by 33.7 +/- 18.1- or 18.1 +/- 6.3- fold, and HPP-CFC by 17.8 +/- 10.5- or 12.7 +/- 9.1- fold, respectively, in cultures containing SCF with IL- or IL-3, as compared with that in control; while SCF alone had little effect. Compared with fresh d3-5FU-BMC, transplantation of the expanded bone marrow cells accelerated the recovery of recipients' peripheral blood cell counts by 1 approximately 3 days and increased the survival rate of the transplanted animals (d3-5FU-BMC group 50% vs expansion group 8U approximately 100%).

Conclusion: SCF in combination with IL-1 or IL-3 synergetically ex vivo expands hematopoietic cells. Transplantation of the expanded bone marrow cells accelerates the recipient's hematopoietic reconstitution.

Publication types

  • English Abstract
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bone Marrow Cells / cytology*
  • Bone Marrow Cells / drug effects
  • Bone Marrow Transplantation
  • Cell Proliferation
  • Female
  • Fluorouracil / pharmacology
  • Granulocyte-Macrophage Progenitor Cells / cytology
  • Hematopoiesis*
  • Hematopoietic Stem Cells / cytology
  • Humans
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Survival Rate

Substances

  • Fluorouracil